Cochrane Evidence Synthesis and Methods ►

Human papillomavirus (HPV) vaccination for the prevention of cervical cancer and other HPV-related diseases: a network meta-analysis

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

We aim to evaluate the safety and efficacy of WHO pre-qualified human papillomavirus (HPV) vaccines given in different dose schedules, in females and males, to prevent cervical cancer and other HPV-related diseases by undertaking a network meta-analysis (NMA). We will rank the different vaccines and dose schedules according to the critical outcomes.

This is a protocol.

Published:

31 May 2022

Authors:

Bergman H, Henschke N, Villanueva G, Loke YK, Golder SP, Dwan K, Crosbie EJ, Kyrgiou M, Platt J, Morrison J

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Bergman H, HenschkeN, VillanuevaG, LokeYK, GolderSP, DwanK, CrosbieEJ, KyrgiouM, PlattJ, MorrisonJ.Human papillomavirus (HPV) vaccination for the prevention of cervical cancer and other HPV-related diseases: a network meta-analysis (Protocol). Cochrane Database of Systematic Reviews 2022, Issue 5. Art. No.: CD015364. DOI: 10.1002/14651858.CD015364.